| NDC-11 (Package) | NDC-9 (Product) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 68071-3202-03 | 68071-3202 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | May 11, 2017 | Dec 31, 2019 | No Longer Used | |
| 63323-0734-10 | 63323-0734 | Pamidronate Disodium | Pamidronate Disodium | 3.0 mg/mL | Ancillary Therapy | Bisphosphonate | Intravenous | May 19, 2002 | Aug 27, 2015 | No Longer Used | |
| 55390-0164-01 | 55390-0164 | Octreotide Acetate | Octreotide Acetate | Hormonal Therapy | Somatostatin Analog | Apr 8, 2005 | Dec 31, 2014 | No Longer Used | |||
| 55513-0058-04 | 55513-0058 | Darbepoetin alfa | Aranesp | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Feb 18, 2011 | Mar 31, 2009 | No Longer Used | |||
| 25021-0463-01 | 25021-0463 | Octreotide acetate | Octreotide Acetate | 50.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Jun 15, 2023 | In Use | ||
| 54868-4030-02 | 54868-4030 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Sep 18, 2000 | In Use | ||
| 00179-1999-01 | 00179-1999 | Estradiol | Estradiol | 0.5 mg/1 | Hormonal Therapy | Estrogen | Oral | Jul 1, 2008 | No Longer Used | ||
| 62332-0650-05 | 62332-0650 | Fulvestrant | Fulvestrant | 50.0 mg/mL | Hormonal Therapy | Estrogen Receptor Antagonist | Intramuscular | Dec 22, 2022 | In Use | ||
| 59676-0312-01 | 59676-0312 | Erythropoietin | Procrit | 10000.0 [iU]/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Jun 1, 1989 | Sep 13, 2012 | In Use | |
| 43598-0233-11 | 43598-0233 | Zoledronic Acid | Zoledronic Acid | 4.0 mg/5mL | Ancillary Therapy | Bisphosphonate | Intravenous | Aug 21, 2023 | In Use | ||
| 23155-0857-03 | 23155-0857 | Anastrozole Tablets | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Feb 28, 2019 | In Use | ||
| 00555-0886-14 | 00555-0886 | Estradiol | Estradiol | 1.0 mg/1 | Hormonal Therapy | Estrogen | Oral | Oct 28, 1997 | Jan 26, 2011 | In Use | |
| 00378-9045-05 | 00378-9045 | Cysteamine bitartrate | Cystagon | 150.0 mg/1 | Chemotherapy | Cystine-Depleting Agent | Oral | Apr 11, 2005 | In Use | ||
| 25021-0467-05 | 25021-0467 | Octreotide acetate | Octreotide Acetate | 1000.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Jun 15, 2023 | In Use | ||
| 70518-4195-00 | 70518-4195 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Oct 1, 2024 | In Use | ||
| 68788-7892-01 | 68788-7892 | Estradiol | Estradiol | 0.5 mg/1 | Hormonal Therapy | Estrogen | Oral | Apr 23, 2021 | May 30, 2023 | No Longer Used | |
| 59676-0310-02 | 59676-0310 | Erythropoietin | Procrit | 10000.0 [iU]/mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Jun 1, 1989 | In Use | ||
| 50090-0491-00 | 50090-0491 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 5.0 mg/1 | Hormonal Therapy | Progestin | Oral | Jan 17, 2019 | In Use | ||
| 00378-9040-05 | 00378-9040 | Cysteamine bitartrate | Cystagon | 50.0 mg/1 | Chemotherapy | Cystine-Depleting Agent | Oral | Apr 11, 2005 | In Use | ||
| 63629-2612-02 | 63629-2612 | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 10.0 mg/1 | Hormonal Therapy | Progestin | Oral | Aug 17, 2007 | In Use | ||
| 00054-0164-13 | 00054-0164 | Anastrozole | Anastrozole | 1.0 mg/1 | Hormonal Therapy | Aromatase Inhibitor | Oral | Jun 28, 2010 | Mar 8, 2018 | No Longer Used | |
| 59762-0055-02 | 59762-0055 | Medroxyprogesterone acetate | Medroxyprogesterone acetate | 2.5 mg/1 | Hormonal Therapy | Progestin | Oral | Nov 2, 2020 | In Use | ||
| 55513-0025-01 | 55513-0025 | Darbepoetin alfa | Aranesp | 100.0 ug/.5mL | Ancillary Therapy | Erythropoiesis-Stimulating Agent | Intravenous, Subcutaneous | Feb 18, 2011 | In Use | ||
| 25021-0464-01 | 25021-0464 | Octreotide acetate | Octreotide Acetate | 100.0 ug/mL | Hormonal Therapy | Somatostatin Analog | Intravenous, Subcutaneous | Jun 15, 2023 | In Use | ||
| 00781-3029-75 | 00781-3029 | Estradiol Valerate | Estradiol Valerate | Hormonal Therapy | Estrogen | Oct 4, 2007 | Dec 31, 2011 | No Longer Used |
Found 12611 results — Export these results
Home